| Literature DB >> 20331848 |
Tomoharu Suzuki1, Shigeru Oshio, Mari Iwata, Hisayo Saburi, Takashi Odagiri, Tadashi Udagawa, Isamu Sugawara, Masakazu Umezawa, Ken Takeda.
Abstract
BACKGROUND: Epidemiological studies have suggested that suspended particulate matter (SPM) causes detrimental health effects such as respiratory and cardiovascular diseases, and that diesel exhaust particles from automobiles is a major contributor to SPM. It has been reported that neonatal and adult exposure to diesel exhaust damages the central nervous system (CNS) and induces behavioral alteration. Recently, we have focused on the effects of prenatal exposure to diesel exhaust on the CNS. In this study, we examined the effects of prenatal exposure to low concentration of diesel exhaust on behaviour and the monoaminergic neuron system. Spontaneous locomotor activity (SLA) and monoamine levels in the CNS were assessed.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20331848 PMCID: PMC2853486 DOI: 10.1186/1743-8977-7-7
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
Figure 1Effect of prenatal exposure to diesel exhaust on spontaneous locomotor activity (SLA) in mice. Each group contained 10 mice. (A) During the initial 60 minutes acclimating to the novel environment, the mice exposed prenatally to diesel exhaust showed lower SLA than the control group. (B) Throughout the testing period, the mice of the exposure group showed lower daily SLA than those of the control group. (C) SLA in each 3 hour period was altered in diesel exhaust-exposed mice. Post hoc analysis revealed that SLA was decreased at some time points. All data are presented as mean ± SEM. The level of statistical significance was set at * P < 0.05.
Figure 2Dopamine and its metabolites in the prefrontal cortex. Dopamine, DOPAC and 3-MT were increased significantly in the exposure group compared to those in the control group. The dopamine turnover (DOPAC/dopamine, 3-MT/dopamine, HVA/dopamine A and [DOPAC + HVA]/dopamine) were not different between the groups. Data are presented as mean ± SEM. The level of statistical significance was set at * P < 0.05.
Figure 3Noradrenaline, its metabolites and turnover in the prefrontal cortex. Noradrenaline, NM and MHPG were increased significantly in the exposure group compared to those in the control group. The noradrenaline turnover (MHPG/noradrenaline) was decreased compared to that in the control group. Data are presented as mean ± SEM. The level of statistical significance was set at * P < 0.05.
Amounts of dopamine and its metabolites (pg mg-1 protein) in each part of the brain.
| Brain region | Group | Content (pg mg-1 protein) | |||
|---|---|---|---|---|---|
| Dopamine | DOPAC | 3-MT | HVA | ||
| Striatum | Control | 270999 ± 30968 | 20710 ± 2573 | 21841 ± 3409 | 32479 ± 3492 |
| Exposed | 319714 ± 14364 | 20197 ± 685 | 22587 ± 1386 | 31276 ± 1956 | |
| Hippocampus | Control | 1520 ± 350 | N.D. | 714 ± 143 | 23816 ± 8826 |
| Exposed | 951 ± 101 | N.D. | 449 ± 35 | 4419 ± 392** | |
| Midbrain | Control | 4387 ± 486 | 2491 ± 191 | 773 ± 71 | 3864 ± 225 |
| Exposed | 3446 ± 361 | 1798 ± 110* | 555 ± 40* | 2847 ± 238* | |
| Cerebellum | Control | 202 ± 29 | N.D. | N.D. | 3225 ± 1152 |
| Exposed | 197 ± 46 | N.D. | N.D. | 4367 ± 1343 | |
| Brainstem | Control | 17959 ± 646 | 57513 ± 2294 | N.D. | 2952 ± 252 |
| Exposed | 15775 ± 395* | 51445 ± 2244 | N.D. | 5382 ± 517** | |
Data are presented as mean ± SEM (n = 10 per group). The statistical significance is shown as *P < 0.05, **P < 0.01; ND, not detectable. Abbreviations: DOPAC, 3,4-dihydroxyphenylacetic acid; HVA, homovanillic acid; 3-MT, 3-methoxytyramine.
Amounts of noradrenaline and its metabolites (pg mg-1 protein) in each part of the brain.
| Brain region | Group | Content (pg mg-1 protein) | ||
|---|---|---|---|---|
| Noradrenaline | NM | MHPG | ||
| Striatum | Control | 1894 ± 310 | N.D. | 31671 ± 2828 |
| Exposed | 1983 ± 278 | N.D. | 23800 ± 1064* | |
| Hippocampus | Control | 9872 ± 1149 | 691 ± 97 | 44283 ± 5051 |
| Exposed | 10668 ± 625 | 788 ± 76 | 30498 ± 1102* | |
| Midbrain | Control | 12498 ± 954 | 410 ± 34 | 22443 ± 1466 |
| Exposed | 12719 ± 633 | 357 ± 34 | 14086 ± 675** | |
| Cerebellum | Control | 4203 ± 312 | 615 ± 60 | 42898 ± 3439 |
| Exposed | 4174 ± 262 | 533 ± 45 | 28305 ± 1730* | |
| Brainstem | Control | 457063 ± 21049 | 25389 ± 1775 | 189692 ± 11607 |
| Exposed | 430512 ± 18333 | 20766 ± 1158* | 165359 ± 16247 | |
Data are presented as mean ± SEM (n = 10 per group). The statistical significance is shown as *P < 0.05, **P < 0.01; ND, not detectable. Abbreviations: MHPG, 4-hydroxy-3-methoxyphenylglycol; NM, normetanephrine.
Dopamine turnover in each part of the brain.
| Brain region | Group | Turnover | |||
|---|---|---|---|---|---|
| DOPAC/dopamine | 3-MT/dopamine | HVA/dopamine | (DOPAC+HVA)/dopamine | ||
| Striatum | Control | 0.076 ± 0.004 | 0.077 ± 0.004 | 0.121 ± 0.004 | 0.197 ± 0.006 |
| Exposed | 0.064 ± 0.002* | 0.071 ± 0.003 | 0.098 ± 0.004* | 0.162 ± 0.005** | |
| Hippocampus | Control | -- | 0.60 ± 0.14 | 24.66 ± 12.22 | -- |
| Exposed | -- | 0.51 ± 0.06 | 5.15 ± 0.64 | -- | |
| Midbrain | Control | 0.61 ± 0.05 | 0.20 ± 0.03 | 0.99 ± 0.13 | 1.601 ± 0.165 |
| Exposed | 0.55 ± 0.03 | 0.17 ± 0.01 | 0.86 ± 0.06 | 1.404 ± 0.079 | |
| Cerebellum | Control | -- | -- | 17.22 ± 5.55 | -- |
| Exposed | -- | -- | 39.49 ± 13.83 | -- | |
| Brainstem | Control | 3.22 ± 0.13 | -- | 0.16 ± 0.01 | 3.38 ± 0.13 |
| Exposed | 3.25 ± 0.09 | -- | 0.35 ± 0.04 | 3.60 ± 0.07 | |
Data are presented as mean ± SEM (n = 10 per group). The statistical significance is shown as *P < 0.05, **P < 0.01; ND, not detectable. Abbreviations: DOPAC, 3,4-dihydroxyphenylacetic acid; HVA, homovanillic acid; 3-MT, 3-methoxytyramine.
Noradrenaline turnover in each part of the brain.
| Brain region | Group | Turnover | |
|---|---|---|---|
| NM/noradrenaline | MHPG/noradrenaline | ||
| Striatum | Control | -- | 20.62 ± 3.14 |
| Exposed | -- | 14.44 ± 2.15 | |
| Hippocampus | Control | 0.069 ± 0.006 | 4.59 ± 0.35 |
| Exposed | 0.074 ± 0.007 | 2.97 ± 0.24** | |
| Midbrain | Control | 0.034 ± 0.002 | 1.84 ± 0.11 |
| Exposed | 0.028 ± 0.003 | 1.12 ± 0.06** | |
| Cerebellum | Control | 0.145 ± 0.011 | 10.82 ± 1.30 |
| Exposed | 0.131 ± 0.013 | 6.87 ± 0.36* | |
| Brainstem | Control | 0.0568 ± 0.003 | 0.415 ± 0.015 |
| Exposed | 0.0487 ± 0.003 | 0.380 ± 0.030 | |
Data are presented as mean ± SEM (n = 10 per group). The statistical significance is shown as *P < 0.05, **P < 0.01; ND, not detectable. Abbreviations: MHPG, 4-hydroxy-3-methoxyphenylglycol; NM, normetanephrine.